An Update on BioMarin Clinical Research and Studies in the PKU Community
|
|
- Bartholomew Fisher
- 5 years ago
- Views:
Transcription
1 An Update on BioMarin Clinical Research and Studies in the PKU Community Barbara Burton, MD, Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Director of PKU Clinic, Children s Memorial Hospital Rob, PKU clinical trial participant Andrew Schorr, Host Shared Experiences, is a Special Edition series focused on clinical trials and PKU, produced by Partners in Marketing in association with Patient Power and sponsored by BioMarin Pharmaceuticals, Inc Clinical Operations Team. Please remember this discussion does not necessarily reflect the views of Patient Power, Partners in Marketing, BioMarin or our partners. Also, remember our program is not a substitute for a discussion with your own doctor. Please consult your doctor for medical advice that s most appropriate for you. Rob s Story Andrew: What does the latest PKU research mean for you? We ll discuss PEG PAL, and other BioMarin clinical studies. What will the future hold for the PKU community? Hear from experts who are directly involved with the research and get your questions answered. It s all next on Patient Power!! Andrew: Hello, I m Andrew Schorr in Seattle. Thanks for joining us! Today we re discussing updates about current BioMarin clinical trials for the PKU community. We re joined by one of the top PKU researchers, Dr. Barbara Burton from Children s Memorial Hospital in Chicago. I always like to begin with someone who has experienced our topic first hand-hand, and today that s 25-year-old Rob from Chicago, who participated in a clinical study. Rob, welcome to the program. Tell us a little bit about why you chose to be in a clinical study. Rob: Well, I ve actually been in a couple of studies. For some reason, even at an early age, I was always very interested in the science behind my PKU. Of course as a 5 or 6 year old, you really don t understand, like particularly for me when my mom would tell me you can t eat certain foods. As I got older, I kept asking questions, and the answers got more in-depth. I used to say to my mom when I was a little kid that if they ever came up with a potential treatment for PKU, I would be the first one in line for it. So when I was given the opportunity to participate in a trial, I jumped at it. I was very fortunate that I really wanted to do it. It s the sense of being able to participate in something I really otherwise would not be able to do. And it s not just the direct impact to me. It s also knowing that I m helping in research that 1
2 really has the potential to make a big difference for a lot of people, just beyond myself. And thankfully I m in a position right now where I really have that time available to do that in my life. I realize that a lot of people out there who, because of time or geographical restrictions, wouldn t have this opportunity. And it has been a very big time commitment for me. For some trials, they might require you to come in five days a week, and that can make it hard to have a fulltime job and still maintain that kind of upkeep. But at the end of the day, I feel it s completely worth it. Andrew: Well, Rob, you certainly are making an important contribution. I hear you re also thinking about medical school. It sounds like you have a lot of great things in front of you for sure. What has the experience of participating in a clinical trials been like for you? Rob: Well, you mentioned medical school, and the irony of it is that I actually graduated college with a degree in economics and my minor was biochemistry. So, I m still working on getting the experience I need, you know I m a little behind being in economics. With trying to get into med school, I need a little more experience in the field. But I think it s probably that kind of background in the sciences that has helped to familiarize me to really familiar myself with the way drugs are developed and the different phases of clinical research. I really have an understanding of the only way we re able to learn about these kinds of treatments and really develop them is through conducting this type of clinical research. Participating in a Phase I clinical study, the first time the study drug is ever actually used in humans, definitely meant that I had a lot of questions. I really wanted to understand the potential benefits, as well as the side effects, which you know, are going to be unknown at that point. For me, it was also understanding the mechanism of how the study drug was administered and how it was supposed to work within my body. And, again, that s really the science part of me coming out. If I m able to understand what the drug is potentially trying to do and how it s supposed to work, that makes me feel more comfortable with participating in it. And other things I ve taken away from the trial and experiences in it is that organization. You know, I started carrying a backpack everywhere with me that has all my study related items in it because the last thing you want to do is if you re supposed to do something related to the study, you don t want to get stranded somewhere and not have what you need. So, I end up putting reminders for myself around my house or at my girlfriend s place that help keep me organized. 2
3 And the staff at the clinic has been phenomenal. I would say really the only drawback is the time commitment. But I look at it as I ve really got a lot of time ahead of me, as far as working. So, I ve no reason not to do it. And this is, again, probably the only time in my life that I ll have this much free time to be able to commit to participating in a clinical study. Andrew: Well Rob, I know your participation and commitment is greatly appreciated. For all of us in the PKU community, the tremendous research and progress that has happened over the last decade has certainly been exciting! PEG PAL Studies Andrew: Now, I want to go to you Dr. Burton. You ve been doing this for a long time and have been involved in several studies. How do you feel about the progress? Dr. Burton: That s right Andrew, there is a lot of research currently happening in PKU and it s really a very exciting time to be working with individuals with PKU. There s been a tremendous amount of progress but yet there are still a lot of unanswered questions. So we look to the clinical studies in progress to learn more, as we explore new treatment options, as well as understand better ways of providing care to our people with PKU. Andrew: Dr. Burton, we get a lot of questions from listeners about the PEG PAL studies. Let s start with the basics, for those who may not be familiar with these studies, what s the focus of this research? Dr. Burton: Well, this is an important study because despite the advancements in PKU treatment, we know that there are still many patients who have trouble controlling their blood phenylalanine levels and suffer the consequences as a result, both in learning and in behavioral issues. These are particularly prominent in our older patients, the adolescents and the adults. We had a major advance a few years back when we had one prescription drug approved by the FDA, that being KUVAN, but about half of patients don t respond to that medication so we really need additional treatments to enable us to have more tools in our tool box for controlling blood phe levels in patients with PKU. So, that s really the purpose of the PEG PAL clinical studies. It represents what we d call enzyme substitution therapy. It won t replace the enzyme PAH that is deficient in patients with PKU, but it does provide a different 3
4 enzyme that is capable of breaking down phe one that is not normally present in humans. So, the purpose of the study is to find out if the study drug, called phenylalanine ammonia-lyase or PAL, works in humans. The study is looking to see if it lowers blood phenylalanine levels and, of course, is monitoring safety of the investigational drug. Andrew: Dr. Burton, what stage are you currently in with this study? Dr. Burton: Well, Andrew trials of potential new drugs typically are run in phases. The first Phase, called Phase I, is really primarily designed to address safety to find out if it s safe to give the drug to people. Based on the results of The Phase I trial of PEG PAL, it was determined that the drug was safe to continue on to phase II studies in people. We are currently in Phase II, where safety continues to be studied very carefully in PKU patients who were receiving repeated doses of the study drug, but at the same time, we can begin and continue to gather more information on how the drug works, on it s efficacy. We re studying a larger number of patients than were studied in Phase I, using different doses of the study drug and at different times to determine what the best way is to give the study drug. Andrew: And when do you expect the PEG PAL phase II study will be completed, and then what happens next? Dr. Burton: Well, the Phase II study is currently recruiting patients at sites across the U.S. and we hope to complete the study by the end of this calendar year, so by the end of Depending on the Phase II study results, we plan to start the Phase III study shortly thereafter. Phase III is the final phase required before the research can be presented to the FDA and other health agencies for potential approval for commercial use. The ADAPT Study Andrew: So it sounds like people should stay tuned. Now, let s talk about a study that was presented at the ACMG conference earlier this year, and that s the ADAPT study, which stands for A Diversified Approach for PKU Treatment. Dr. Burton Tell us about the study and what you found. Dr. Burton: Well, the ADAPT study is one that was done at 3 PKU clinics around the country, including ours. Really the purpose of the study was to investigate the frequency of learning and behavior problems in all patients in a PKU clinic and to 4
5 improve care provided by the clinics. What we found is that many individuals were provided additional services for these issues based on the screening test results. Andrew: Dr. Burton, what does that mean for your clinic? Dr. Burton: Well, in our clinic, we ve learned that the old way we used to use to figure out which of our patients were having significant difficulty, just doesn t work out. We were asking them how they re feeling, doing some standard questioning, like: are there any problems at school? Problems at work? Problems with a relationship? But this study has taught us that that sort of questioning in obtaining a history from the patient is really not very effective at identifying the patients who need additional help. When you do a more extensive screening paper and pencil questionnaires, it turns out that many patients will respond yes to some very telling questions, and as we were doing this, then I could go back with the patient and probe some of these issues. We were surprised to find that there are many patients out there having very significant difficulty when we wouldn t have guessed this was the case just from our cursory, initial assessment in taking a history at the patient s visit. So, I think these types of screening tools are very helpful in opening up conversations with patients about some of the issues identified as we really look to identify these learning and behavior problems. It opens up the discussion and it gives us another tool we can use. Andrew: And if someone wants to stay up-to-date about current clinical studies? What s the best resource? Dr. Burton: Really, I think the best way to get more information about ongoing clinical trials is to talk to your PKU clinical team and ask them how you might participate. Many clinic doctors will be aware of what s happening, even if they are not actively participating in the clinical studies, and can refer you to a participating clinic. You can also go to clinicaltrials.gov and search for PEG PAL or PKU, or some patients like to go to the medical literature directly and use pubmed.org. But I think, overall, your clinic is probably your best resource. The PKU 016 Study Andrew: Dr. Burton, it seems, it s really about staying in a conversation with your as a wonderful way to help staying informed. Now, there s another clinical study you re involved in, and that s PKU 016. Tell us a little bit about this study. 5
6 Dr. Burton: Well, Andrew, PKU-016 is an interesting study involving sapropterin dihydrochloride, which is the same active ingredient that s in KUVAN. What we know about the study drug from the previous clinical trials is that it lowers phenylalanine levels in about half of all PKU patients. In PKU-016, we are investigating whether the study drug improves learning and behavior symptoms experienced by some people with PKU. It s important to understand this because these symptoms may have a tremendous impact on the lives of people with PKU. In addition this is a placebo-controlled study, and there will be a group of patients who receive a placebo or inactive drug, and they ll be compared with the patients receiving the study drug. Then after a period of time, all of the patients will receive the study drug. One of the goals of the study is to evaluate whether learning and behavior changes in people who are on study drug when compared to placebo regardless of changes are seen in their blood phe levels. In other words, does this study drug have an effect on learning and behavior even if the blood phe level is not significantly lowered? During the first part of the study, the participants will not know whether they are receiving the study drug or the placebo. Andrew: Are there any additional BioMarin clinical studies in children with PKU? Dr. Burton: Yes, actually there is one. We are conducting a 7 year study in the PKU pediatric population to determine the effects, if any, on the development of children age 0-6 years who are using Kuvan. It may also provide additional safety information on the use of Kuvan in this age group. We currently have enrolled approximately 55 out of 60 children with PKU in the study, all of these children being responsive to Kuvan, and have followed them thus far for a period of one month to approximately 2 years and continue to collect safety data. Andrew: Dr. Burton, it sounds like you re collecting a lot of useful information that may potentially help in the management of PKU. That s wonderful. Dr. Barbara Burton, professor of Pediatrics at Northwestern University Feinberg School of Medical and Director of the PKU Clinic at Children s Memorial Hospital in Chicago. So, let s go back to Rob. With all of the clinical research happening, Rob what is your advice to those who might be thinking about participating in a clinical study? Rob: You know, for me, when I walk away from it with a sense of being a part of something bigger than myself. And I ve gone into different trials that I ve been in not necessarily expecting the study drug to work but always hoping that it will. And I ve participated in studies where the drug didn t work for me. But for any small 6
7 chance that I can help the researchers and help them gather more information is completely worth it. Andrew: Well, it certainly sounds like there is a lot coming down the pike for the PKU community and certainly I hope it makes a real difference for patients. I want to thank all of our guests today! If you have questions, please us at questions@pkuclinicaltrials.com. And remember the best way to stay up-to-date about the latest information about participating in clinical studies is to visit clinicaltrials.gov or talk to your healthcare team. If you have a moment, we d really appreciate you sending us feedback about the program. I want to thank our guests again! Remember knowledge can be the best medicine of all. I m Andrew Schorr. Please remember this discussion does not necessarily reflect the views of Patient Power, Partners in Marketing, BioMarin or our partners. Also, remember our program is not a substitute for a discussion with your own doctor. Please consult your doctor for medical advice that s most appropriate for you. 7
Hello and welcome to Patient Power sponsored by UCSF Medical Center. I m Andrew Schorr.
The Integrated Approach to Treating Cancer Symptoms Webcast March 1, 2012 Michael Rabow, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center,
More informationParkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. What is Parkinson s Disease?
Parkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center, its medical staff or Patient
More information18 INSTRUCTOR GUIDELINES
STAGE: Ready to Quit You are a community pharmacist and have been approached by a 16-year-old girl, Nicole Green, who would like your advice on how she can quit smoking. She says, I never thought it would
More informationUnraveling Recent Cervical Cancer Screening Updates and the Impact on Your Practice
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationAs a Lung Cancer Patient, What Information Do I Need to Make the Best Choices?
As a Lung Cancer Patient, What Information Do I Need to Make the Best Choices? Mary Ellen Hand, RN, BSN Nurse Coordinator Rush University Medical Center Emma Shtivelman, PhD Chief Scientist Cancer Commons
More informationLet me introduce you to her. That s Barbara Scribner who joins us from Kent, Washington. Barbara, thank you so much for joining us.
Lung Cancer: Detection and Early Intervention Webcast November 30, 2009 Douglas E. Wood, M.D. Jason Chien, M.D., M.S. Barbara Scribner Please remember the opinions expressed on Patient Power are not necessarily
More informationHow a CML Patient and Doctor Work Together
How a CML Patient and Doctor Work Together Recorded on: November 5, 2012 Jessica Altman, M.D. Assistant Professor, Department of Medicine, Hematology Oncology Division Feinberg School of Medicine, Northwestern
More informationWelcome to Progress in Community Health Partnerships latest episode of our Beyond the Manuscript podcast. In
Beyond the Manuscript 45 Podcast Interview Transcript Larkin Strong, Zeno Franco, Mark Flower Welcome to Progress in Community Health Partnerships latest episode of our Beyond the Manuscript podcast. In
More informationNormalizing STI Screening: The Patient Impact
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/womens-health-update/normalizing-sti-screening-the-patientimpact/10074/
More informationDefeating Colon Cancer with Surgery
Defeating Colon Cancer with Surgery Recorded on: September 19, 2012 Alessandro Fichera, M.D. Director, Colorectal Surgical Oncology Program, Seattle Cancer Care Alliance Please remember the opinions expressed
More informationInvestigating Plinabulin for Prevention of Chemotherapy-Induced Neutropenia
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/project-oncology/origins-and-impacts-severe-neutropenia-newpharmacotherapy/9650/
More informationUnderstanding Acute Kidney Injury and Its Impact
Understanding Acute Kidney Injury and Its Impact Recorded on: March 7, 2013 Chi-Yuan Hsu, M.D., M.S. Chief of the Division of Nephrology, UCSF Department of Medicine UCSF Medical Center Raymond Hsu, M.D.
More informationPCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/pcsk9-antibodies-dyslipidemia-efficacy-safety-and-nonlipid-effects/8335/
More informationOptions in HIV Prevention A Participant-Centered Counseling Approach
Options in HIV Prevention A Participant-Centered Counseling Approach Options Counseling Flipchart, Version 3.0, 10 Oct 2017 Enrollment Visit Welcome and thank you! 3 HOPE Adherence Counseling CHOICE: Helping
More informationCombining Individualized Treatment Options with Patient-Clinician Dialogue
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationNews from ASH: Updates on Lymphoma and Other Blood Cancers ASH Conference Coverage December 8, 2008 Andrew Evens, D.O.
News from ASH: Updates on Lymphoma and Other Blood Cancers ASH Conference Coverage December 8, 2008 Andrew Evens, D.O. Please remember the opinions expressed on Patient Power are not necessarily the views
More information9 INSTRUCTOR GUIDELINES
STAGE: Ready to Quit You are a clinician in a family practice group and are seeing 16-yearold Nicole Green, one of your existing patients. She has asthma and has come to the office today for her yearly
More informationPKU, KUVAN, and You PKU treatment and support for adults and young adults
PKU, KUVAN, and You PKU treatment and support for adults and young adults An educational brochure brought to you by BioMarin Pharmaceutical Inc. Phe control it s a lifelong goal! Most young people with
More informationScouter Support Training Participant Workbook
Scouter Support Training Participant Workbook Version 2.1 June 15, 2011 Minor changes November 5, 2012 For use with the Scouter Support Playbook Scouter Support Training: Trainer s Manual 2 Participant
More informationFine-Tuning Immunotherapy to Treat Prostate Cancer Recorded on: April 24, 2013
Fine-Tuning Immunotherapy to Treat Prostate Cancer Recorded on: April 24, 2013 John Corman, M.D. Medical Director, Floyd & Delores Jones Cancer Institute at Virginia Mason Virginia Mason Medical Center
More informationCarrier Screening in your Practice Is it Time to Expand your View?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-industry-feature/carrier-screening-your-practice-it-time-expandyour-view/9648/
More informationLetter to the teachers
Letter to the teachers Hello my name is Sasha Jacombs I m 12 years old and I have had Type 1 Diabetes since I was four years old. Some of the people reading this may not know what that is, so I had better
More informationThe HPV Data Is In What Do the Newest Updates in Screening Mean For Your Patients?
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationThe Connecticut Cancer Partnership
The Connecticut Cancer Partnership Guest Expert: Lucinda Connecticut Cancer Partnership Program Director www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Dr. Ed Chu and
More informationAbout Health TV with Jeanne Blake Prostate cancer update
About Health TV with Jeanne Blake Prostate cancer update www.abouthealth.com Welcome to About Health TV. We recently aired a program on About Health TV about prostate cancer, and during that program we
More informationMinimally Invasive Surgery Offers Promise for Pancreatic Cancer Patients
Minimally Invasive Surgery Offers Promise for Pancreatic Cancer Patients Recorded on: August 1, 2012 Venu Pillarisetty, M.D. Surgical Oncologist Seattle Cancer Care Alliance Please remember the opinions
More informationWhat is the Economic Impact of Autism Spectrum Disorder?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/autism-spectrum/what-is-economic-impact-autism-spectrumdisorder/10263/
More informationFlu Vaccines: Questions and Answers
Flu Vaccines: Questions and s Question 1 Does the flu shot give me the flu? Does the flu shot give me the flu? I heard people get sick after the shot. Well, I m really glad you asked that question about
More informationGenetic Counselor: Hi Lisa. Hi Steve. Thanks for coming in today. The BART results came back and they are positive.
Hi, I m Kaylene Ready, a genetic counselor who specializes in the education and counseling of individuals at high-risk for hereditary breast and ovarian cancer syndrome. Women with an inherited BRCA 1
More informationMaking Connections: Early Detection Hearing and Intervention through the Medical Home Model Podcast Series
Making Connections: Early Detection Hearing and Intervention through the Medical Home Model Podcast Series Podcast 2 Utilization of the Teach-Back Methodology in Early Hearing Detection and Intervention
More informationThis is an edited transcript of a telephone interview recorded in March 2010.
Sound Advice This is an edited transcript of a telephone interview recorded in March 2010. Dr. Patricia Manning-Courtney is a developmental pediatrician and is director of the Kelly O Leary Center for
More informationNOT ALONE. Coping With a Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD)
NOT ALONE Coping With a Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) FOR THE NEWLY DIAGNOSED AND THEIR LOVED ONES, FROM THOSE WHO HAVE TRAVELED THIS ROAD BEFORE YOU We re not alone. We re
More informationIron Deficiency Anemia in Patients with Inflammatory Bowel Disease ReachMD Page 1 of 7
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationOne of the areas where it's certainly made it difference is with the transplantation of the liver. Dr. Roberts thinks so much for joining us.
Benefits and Risks of Living Donor Liver Transplant Webcast May 28, 2008 John Roberts, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center,
More informationUnder the Supervision of: Prof. Judy Freedman Fask, College of the Holy Cross
Interviewee: Jamie Lard Interviewers: Marissa Steppacher and Lauren Donovan College of the Holy Cross Interpreters: Kristin Olsen and Heather Webber Northeastern University Transcriber: Kyla Donovan, Salter
More informationDr. Coakley, so virtual colonoscopy, what is it? Is it a CT exam exactly?
Virtual Colonoscopy Webcast January 26, 2009 Fergus Coakley, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center, its medical staff or Patient
More informationI don t want to be here anymore. I m really worried about Clare. She s been acting different and something s not right
I just can t take what s happening at home anymore Clare 23 mins Instagram When your friend is thinking about suicide I don t want to be here anymore... I m really worried about Clare. She s been acting
More informationAcoustic Neuroma: Treatment Planning
Acoustic Neuroma: Treatment Planning Recorded on: June 12, 2012 Andrew J. Fishman, M.D. Otologist/Neurotologist and Skull Base Surgeon Northwestern Memorial Hospital Stacey Bock Please remember the opinions
More informationUnderstanding Treatment Options for Phenylketonuria Webcast January 2011 Marie LeFrancois, Dt.P. John Mitchell, M.D. Anna Maiorino
Understanding Treatment Options for Phenylketonuria Webcast January 2011 Marie LeFrancois, Dt.P. John Mitchell, M.D. Anna Maiorino Please remember that the views expressed on Patient Power do not necessarily
More informationSickle Cell Disease: How Should YOU Reassess Management & Treatment?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/changing-conversation-sickle-cell-disease/sickle-cell-disease-howshould-you-reassess-management-treatment/10184/
More informationDeciphering Chronic Pain and Pain Medicine
Deciphering Chronic Pain and Pain Medicine Deciphering Chronic Pain and Pain Medicine Hello and welcome to Primary Care Today on ReachMD. I m your host, Dr. Brian McDonough, and I m very happy to have
More informationMeeting a Kid with Autism
What s up with Nick? When school started, we had a new kid named Nick. He seemed a little different. My friends and I wondered, What's up with Nick? Turns out, Nick has autism. What is Autism This year,
More informationHow to Work with the Patterns That Sustain Depression
How to Work with the Patterns That Sustain Depression Module 5.2 - Transcript - pg. 1 How to Work with the Patterns That Sustain Depression How the Grieving Mind Fights Depression with Marsha Linehan,
More informationsuicide Part of the Plainer Language Series
Part of the Plainer Language Series www.heretohelp.bc.ca What is? Suicide means ending your own life. It is sometimes a way for people to escape pain or suffering. When someone ends their own life, we
More informationUW MEDICINE PATIENT EDUCATION. Support for Care Partners. What should my family and friends know?
UW MEDICINE PATIENT EDUCATION Support for Care Partners What should my family and friends know? From Jane, former care partner: It s about keeping yourself sane and healthy. I had very little time for
More information19 INSTRUCTOR GUIDELINES
STAGE: Recent Quitter You are a pharmacist in a smoking cessation clinic and you receive a phone call from one of your patients, Ms. Onitay. She is moderately panicked and tells you that she has a swollen
More informationI m NOT Interested in Anything I m NOT Interested In!!
I m NOT Interested in Anything I m NOT Interested In!! A Teenager s Guide to ADHD Booklet 1 In a Series Chesterfield County Public Schools I don t want to hear anymore about this ADHD junk!!! People won
More informationMaking decisions about therapy
JANUARY 2011 Making decisions about therapy Making decisions about treating your HIV may feel overwhelming. Developing a plan that helps you think about, plan for and make treatment decisions can help.
More information"PCOS Weight Loss and Exercise...
"PCOS Weight Loss and Exercise... By Dr. Beverly Yates Dr. of Naturopathic Medicine, PCOS Weight Loss Expert & Best Selling Author Table of Contents Introduction... 2 If You Are Dieting Do You Need To
More informationAdvances in Pediatric Bone Marrow Transplant Webcast March 4, 2011 Scott Baker, M.D., M.S. Anna Robinson. Introduction
Advances in Pediatric Bone Marrow Transplant Webcast March 4, 2011 Scott Baker, M.D., M.S. Anna Robinson Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle
More informationRheumatoid Arthritis: Counseling Women Who Are Trying to Conceive
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationCarotid Ultrasound Scans for Assessing Cardiovascular Risk
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/carotid-ultrasound-scans-for-assessing-cardiovascularrisk/4004/
More informationStep Five. Admitted to ourselves and another human being the exact nature of our wrongs.
Step Five Admitted to ourselves and another human being the exact nature of our wrongs. Our Basic Text tells us that Step Five is not simply a reading of Step Four. Yet we know that reading our Fourth
More informationThis American Life Transcript. Prologue. Broadcast June 25, Episode #411: First Contact. So, Scott, you were born without hearing, right?
Scott Krepel Interview from TAL #411 1 This American Life Transcript Prologue Broadcast June 25, 2010 Episode #411: First Contact Is that Marc? Yes, that s Marc speaking for Scott. So, Scott, you were
More informationStudy Buddies. More Info, Please. By Meredith Matthews. Teens talk about being part of medical trials or not.
Study Buddies By Meredith Matthews Teens talk about being part of medical trials or not. The next time you pop a pill for a backache or a cold, check out the label. It may say the drug is safe and effective
More informationBreast Cancer Imaging Webcast October 21, 2009 Peter Eby, M.D. Introduction
Breast Cancer Imaging Webcast October 21, 2009 Peter Eby, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer Care Alliance, its medical staff or
More informationA caregiver s guide to. Immuno-Oncology. Things you may want to know as you care for someone receiving cancer immunotherapy.
A caregiver s guide to Immuno-Oncology Things you may want to know as you care for someone receiving cancer immunotherapy Your logo Table of contents 4 Figuring out your role as a caregiver 8 Helping your
More informationkeep track of other information like warning discuss with your doctor, and numbers of signs for relapse, things you want to
Helping you set your brain free from psychosis. www.heretohelp.bc.ca This book was written by Sophia Kelly and the BC Schizophrenia Society, for the BC Partners for Mental Health and Addictions Information.
More informationWHEN OBAMA BECAME PRESIDENT: MEANINGS OF AGING IN A TIME OF PARADIGM SHIFTS
WHEN OBAMA BECAME PRESIDENT: MEANINGS OF AGING IN A TIME OF PARADIGM SHIFTS Jacquelyn Browne Ph.D., LCSW Principal Investigator Yulia Watters Ph.D., LMFT Co Principal Investigator OBJECTIVES OF THE STUDY
More informationMRC talks podcast: Career inspirations: Daniel Freeman, clinical psychologist January 2019
Presenter: Welcome to the MRC talks podcast. I m Isabel Harding. For 2019 we re launching a 12-part career inspirations series. We ll feature 12 scientists, all working in different areas of medical research,
More informationProblem Situation Form for Parents
Problem Situation Form for Parents Please complete a form for each situation you notice causes your child social anxiety. 1. WHAT WAS THE SITUATION? Please describe what happened. Provide enough information
More informationCertified Peer Specialist Training
Certified Peer Specialist Training Feb 19 Mar 2, 2018 Scranton CPS Training Facilitated by RI Consulting (formerly Recovery Opportunity Center) Date & Time: Training is Feb 19 Mar 2, 2018 and runs approximately
More informationDr. Gopal, are you encouraged in the direction of where research is headed and its benefit for patients?
Targeting the Tumor in Lymphoma July 8, 2009 Ajay Gopal Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer Care Alliance, its medical staff or Patient
More informationThe Latest in Kidney and Liver Transplant Webcast August 14, 2008 Connie Davis, M.D. Robert Carithers, M.D. Introduction
The Latest in Kidney and Liver Transplant Webcast August 14, 2008 Connie Davis, M.D. Robert Carithers, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UW Medicine,
More informationYour Personal Guide to Fundraising
Your Personal Guide to Fundraising Help Children s Medical Research Institute to Beat Childhood Disease. Please donate by phone or fax: P.+1800 436 437 F.+61 2 8865 2801 Please donate online: www.cmri.org.au/donate
More informationThe Expanding Value of Biomarkers in NSCLC Treatment
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/closing-gaps-nsclc/the-expanding-value-of-biomarkers-in-nsclctreatment/10283/
More informationHigher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/higher-risk-lowered-age-new-colorectal-cancerscreening-guidelines/10309/
More informationORIENTATION SAN FRANCISCO STOP SMOKING PROGRAM
ORIENTATION SAN FRANCISCO STOP SMOKING PROGRAM PURPOSE To introduce the program, tell the participants what to expect, and set an overall positive tone for the series. AGENDA Item Time 0.1 Acknowledgement
More informationAspirin Resistance and Its Implications in Clinical Practice
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/aspirin-resistance-and-its-implications-in-clinicalpractice/3819/
More informationSeven Questions to Ask Your Next Dentist
Seven Questions to Ask Your Next Dentist COMMUNICATION Your dentist should be communicating with you on a regular basis in a way you understand. CONNECTION Do you feel like you actually know your dentist?
More informationTreating Lung Cancer: Past, Present, & Future Dr. Ramiswamy Govindan Washington University November, 2009
Treating Lung Cancer: Past, Present, & Future Dr. Ramiswamy Govindan Washington University November, 2009 GRACE, the Global Resource for Advancing Cancer Education, is pleased to provide the following
More informationParticipant Information Sheet
Appendix A Participant Information Sheet for Young People Participant Information Sheet Exploring experiences of disclosure and non-disclosure amongst young adolescents who hear voices Hi. My name is Rachel
More informationMAKING DECISIONS TOGETHER. Being an Active Partner in Your Treatment and Recovery
MAKING DECISIONS TOGETHER Being an Active Partner in Your Treatment and Recovery The Journey of Mental Health Recovery U.S. Adults Living With: Schizophrenia 10 out of 1000 Schizoaffective 2 to 5 out of
More informationSexual Feelings. Having sexual feelings is not a choice, but what you do with your feelings is a choice. Let s take a look at this poster.
Sexual Feelings It may be your first instinct to deny that your child will ever have sexual feelings. You may even do everything in your power to suppress those feelings if they do surface. You won t succeed
More informationSmoking Cessation Strategies for the 21st Century
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/smoking-cessation-strategies-for-the-21stcentury/3862/
More informationThe Recovery Journey after a PICU admission
The Recovery Journey after a PICU admission A guide for families Introduction This booklet has been written for parents and young people who have experienced a Paediatric Intensive Care Unit (PICU) admission.
More informationHIV Housing Care Continuum Webinar 1 August 3, 2016
Page 1 HIV Housing Care Continuum August 3, 2016 Rita Flegel: Hello and welcome. I'm Rita Flegel, the Director of HUD's Office of HIV/AIDS Housing. And presenting with me today is Amy Palilonis also from
More informationInterviewer: Tell us about the workshops you taught on Self-Determination.
INTERVIEW WITH JAMIE POPE This is an edited translation of an interview by Jelica Nuccio on August 26, 2011. Jelica began by explaining the project (a curriculum for SSPs, and for Deaf-Blind people regarding
More informationBenefits of Survivorship Treatment Care Plans Webcast May 13, 2009 Scott Baker, M.D., M.S. Donald Wilhelm. Introduction
Benefits of Survivorship Treatment Care Plans Webcast May 13, 2009 Scott Baker, M.D., M.S. Donald Wilhelm Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle
More informationHello and welcome to Patient Power sponsored by Northwestern Memorial Hospital. I'm Andrew Schorr.
Brain Tumor Clinical Trials Webcast November 22, 2011 Sean Grimm, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Northwestern Memorial Hospital, its medical
More informationActive Living with Arthritis Podcast #11 Doing What You Love: Gardening, Golf, and Tennis when Living with Knee Osteoarthritis
Active Living with Arthritis Podcast #11 Doing What You Love: Gardening, Golf, and Tennis when Living with Knee Osteoarthritis Karen: Welcome to another Active Living with Arthritis podcast, presented
More informationDr. Susan Steen: I have a special interest in dementia and Alzheimer s in related disorders.
Saving Memories With a Shake: The Alzheimer's Drink Susan Steen, MD Susan Steen, MD, a neurologist at South Tampa Memory Center/President, Axiom Clinical Research, talks about a new medical food for Alzheimer's
More informationFINDING THE RIGHT WORDS IN ADVANCED AND METASTATIC BREAST CANCER (ABC/MBC)
FINDING THE RIGHT WORDS IN ADVANCED AND METASTATIC BREAST CANCER (ABC/MBC) Real people. Real communication. Making a real difference. 000989_NOV19_Breast_Cancer_Language_Guide_HCPs_V4_CL.indd 1 What do
More informationWe know that treatments are now targeting genes, but does genetics play a bigger role in cancer outside of that?
Welcome to the 3Ps of Cancer podcast, where we'll discuss prevention, preparedness, and progress in cancer treatments and research. Brought to you by the University of Michigan Rogel Cancer Center. I'm
More informationScript: Placebo Effect Matt Biggers, Amelia Hulbert, Kathryn Valchar
Script: Placebo Effect Matt Biggers, Amelia Hulbert, Kathryn Valchar Cast of Characters Scene 1 Doctor Ruth Cannon Patient 1 Mark Bridges Patient 2 Stella Brody Doctor Doris Bradley Open on a doctor s
More informationwe ve got fine tuning possibilities, and that s certainly possible with modifying the enzymes that synthesize or degrade the endogenous cannabinoids
The CCIC Podcast February 24, 2015 This month: Prof. Steve Alexander Interview by Dr. Mark A. Ware www.ccic.net/podcast Introduction Hello and welcome to the CCIC Podcast. The CCIC Podcast is a series
More informationThe Biomechanical Approach to Heart Disease
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/the-biomechanicalapproach-to-heart-disease/3912/
More informationGenotype Testing on Current Cervical Cancer Algorithms
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationI just want to go back to your early days and how you got started in the fitness
Josh Anderson and Nate Miyaki Interview: 12/17/2013 Josh Anderson: industry. I just want to go back to your early days and how you got started in the fitness Nate Miyaki: Well basically I was kind of an
More informationSelf Esteem and Purchasing Behavior Part Two.
Self Esteem and Purchasing Behavior Part Two www.howtodoubleyourbusiness.com G: Hi Sharon, honey. S: Hi, honey. G: Well, I want everybody to know that Sharon and I just did a terrific recording and went
More informationBOOKLET ONE. Introduction to Behavioural Activation for Depression
BEHAVIOURAL ACTIVATION FOR DEPRESSION BOOKLET ONE Introduction to Behavioural Activation for Depression Contents Missing sources of wellbeing 2-3 Sources of misery 4-5 What we do when we feel down 6-7
More informationNeonatal Diabetes: A Special Case of Type 1 Diabetes
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/neonatal-diabetes-a-special-case-of-type-1-
More informationHeart Attack Recovery: Understanding the World s Smallest Heart Pump Webcast February 4, 2009 Antony Kim, M.D.
Heart Attack Recovery: Understanding the World s Smallest Heart Pump Webcast February 4, 2009 Antony Kim, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Oregon
More information2 INSTRUCTOR GUIDELINES
STAGE: Not Ready to Quit (Ready to cut back) You have been approached by Mr. Faulk, a healthy young male, aged 28, who has applied to become a fireman and has a good chance of being offered the job. His
More informationMycoplasma Genitalium: Get to Know the Hidden STI
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/womens-health-update/mycoplasma-genitalium-get-to-know-hiddensti/9501/
More informationREASON FOR REFLECTING
Reflecting Skills Paraphrase and Reflection of Feeling REASON FOR REFLECTING Reflecting is a verbal way of communicating empathy A form of feedback that enables the client to confirm or correct the impression
More informationWhat s the Latest in Prostate Cancer Immunotherapy Options?
What s the Latest in Prostate Cancer Immunotherapy Options? Jeri Kim, MD Associate Professor, Department of Geritourinary Medical Oncology The University of Texas MD Anderson Cancer Center Sumit K. Subudhi,
More informationHow to Work with the Patterns That Sustain Depression
How to Work with the Patterns That Sustain Depression Module 2.2 - Transcript - pg. 1 How to Work with the Patterns That Sustain Depression Two Powerful Skills to Reduce a Client s Depression Risk with
More informationPromote Leaders. Teresa Schmidt
Teresa Schmidt I am super excited to share this training segment with you and I am confident it will support your efforts in promoting out Units. Let s open up with a quote from my absolute favorite trainer,
More informationLiving well today...32 Hope for tomorrow...32
managing diabetes managing managing managing managing managing managing diabetes Scientific research continually increases our knowledge of diabetes and the tools to treat it. This chapter describes what
More information